Skip to content

Clinical trials

Phase 1 Inflammatory Bowel Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 1 Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20095
20103
20112
20125
20133
20144
20157
20162
20173
20187
20192
20207
20215
202210
20236
20245
20257
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Recruiting11
Terminated10
Not yet recruiting8
Withdrawn6
Unknown status5
Active, not recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Pfizer6
Theravance Biopharma4
Stanford University3
Brigham and Women's Hospital2
Bristol-Myers Squibb2
Direct Biologics, LLC2
Jiangsu vcare pharmaceutical technology co., LTD2
McMaster Children's Hospital2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases98
Colitis, Ulcerative40
Crohn Disease30
Colitis4
Arthritis, Psoriatic3
Clostridium Infections3
Gastrointestinal Diseases3
Intestinal Diseases3
Lupus Erythematosus, Systemic3
Psoriasis3

Trials

Showing 76 to 98 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.